U.S. Gastric Cancer Diagnostics Market Is Likely To Witness Huge Growth
U.S. Gastric Cancer Diagnostics Market Summary The U.S. gastric cancer diagnostics market size was valued at USD 489.09 million in 2024 and is projected to reach USD 897.20 million by 2033, expanding at a CAGR of 7.08% from 2025 to 2033. Market growth is being driven by continuous advancements in diagnostic technologies, rising awareness among patients and healthcare providers, and the expansion of healthcare infrastructure across the country. According to the American Cancer Society (ACS), gastric cancer accounted for 26,890 new cases and 10,880 deaths in 2024, with an estimated 30,300 new cases and 10,780 deaths expected in 2025, highlighting the growing healthcare burden. Innovative technologies such as liquid biopsies, next-generation sequencing (NGS), and AI-driven imaging are transforming the landscape of gastric cancer diagnostics. These methods support early detection, accurate staging, and a deeper understanding of tumor biology, ultimately enabling the devel...